Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis

被引:13
作者
Fang, Miao [1 ]
Yao, Min [1 ]
Yang, Jie [1 ]
Zheng, Wen-Jie [2 ]
Wang, Li [3 ]
Yao, Deng-Fu [2 ]
机构
[1] Nantong Univ, Med Sch, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, 20 West Temple Rd, Nantong 226001, Jiangsu, Peoples R China
[3] Nantong Univ, Dept Med Informat, Med Sch, Nantong 226001, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocarcinogenesis; CD44; Nonalcoholic fatty liver disease; Animal model; Dynamic expressions; HEPATOCELLULAR-CARCINOMA; LIPID-ACCUMULATION; PROGNOSTIC VALUE; LIVER-DISEASE; POPULATION; METASTASIS; INVASION; MODELS;
D O I
10.4251/wjgo.v12.i1.66
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND Prevalence of nonalcoholic fatty liver disease (NAFLD) is rapidly increasing, and NAFLD has become one of the most common chronic liver diseases worldwide. With abnormal CD44 activation, the severe form of NAFLD can progress to liver cirrhosis and hepatocellular carcinoma (HCC). Thus, the molecular mechanism of CD44 in NAFLD needs to be identified. AIM To investigate the relationship between CD44 activation and malignant transformation of rat hepatocytes under nonalcoholic lipid accumulation. METHODS Sprague-Dawley rats were fed a high-fat (HF) for 12 wk to entice NAFLD and then with HF plus 2-fluorenylacetamide (0.05%) to induce HCC. Rats were sacrificed every 2 wk, and subsequently divided into the groups based on liver pathological examination (hematoxylin and eosin staining): NAFLD, denaturation, precancerosis, HCC, and control. Liver CD44 mRNA was detected by OneArray. Liver fat as assessed by Oil red O staining or CD44 by immunohistochemical assay was compared with their integral optic density. Serum CD44, alanine aminotransferase, aspartate aminotransferase, triglyceride, total cholesterol, and AFP levels were quantitatively tested. RESULTS Elevated CD44 was first reported in hepatocarcinogenesis, with increasing expression from NAFLD to HCC at the protein or mRNA level. The CD44 integral optic density values were significantly different between the control group and the NAFLD (t = 25.433, P < 0.001), denaturation (t = 48.822, P < 0.001), precancerosis (t = 27.751, P < 0.001), and HCC (t = 16.239, P < 0.001) groups, respectively. Hepatic CD44 can be secreted into the blood, and serum CD44 levels in HCC or precancerous rats were significantly higher (P < 0.001) than those in any of the other rats. Positive correlations were found between liver CD44 and CD44 mRNA (r(s) = 0.373, P = 0.043) and serum CD44 (r(s) = 0.541, P = 0.002) and between liver CD44 mRNA and serum CD44 (r(s) = 0.507, P = 0.004). Moreover, significant correlations were found between liver CD44 and liver AFP (r(s) = 0.572, P = 0.001), between serum CD44 and serum AFP (r(s) = 0.608, P < 0.001), and between CD44 mRNA and AFP mRNA (r(s) = 0.370, P = 0.044). CONCLUSION The data suggested that increasing CD44 expression is associated with the malignant transformation of hepatocytes in NAFLD.
引用
收藏
页码:66 / 76
页数:12
相关论文
共 40 条
[1]   CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line [J].
Asai, Ryoma ;
Tsuchiya, Hiroyuki ;
Amisaki, Masataka ;
Makimoto, Kazuki ;
Takenaga, Ai ;
Sakabe, Tomohiko ;
Hoi, Shotaro ;
Koyama, Shigemi ;
Shiota, Goshi .
CANCER MEDICINE, 2019, 8 (02) :773-782
[2]   Generic chemoprevention of hepatocellular carcinoma [J].
Athuluri-Divakar, Sai Krishna ;
Hoshida, Yujin .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1440 (01) :23-35
[3]   The Natural Course of Non-Alcoholic Fatty Liver Disease [J].
Bertot, Luis Calzadilla ;
Adams, Leon Anton .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
[4]   Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science [J].
Brar, Gurmehr ;
Tsukamoto, Hidekazu .
JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) :218-225
[5]   Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature [J].
Calandri, Marco ;
Mauri, Giovanni ;
Yevich, Steven ;
Gazzera, Carlo ;
Basile, Domenico ;
Gatti, Marco ;
Veltri, Andrea ;
Fonio, Paolo .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (05) :639-647
[6]   Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells [J].
Castelli, Germana ;
Pelosi, Elvira ;
Testa, Ugo .
CANCERS, 2017, 9 (09)
[7]   Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans [J].
Chen, Kan ;
Ma, Jianbo ;
Jia, Xiaoyuan ;
Ai, Wen ;
Ma, Zhongren ;
Pan, Qiuwei .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2019, 1871 (01) :117-125
[8]   The prognostic value of Niemann-Pick C1-like protein 1 and Niemann-Pick disease type C2 in hepatocellular carcinoma [J].
Chen, Ke-Ji ;
Jin, Ri-Ming ;
Shi, Chun-Chao ;
Ge, Rui-Liang ;
Hu, Lei ;
Zou, Qi-Fei ;
Cai, Quan-Yu ;
Jin, Guang-Zhi ;
Wang, Kui .
JOURNAL OF CANCER, 2018, 9 (03) :556-563
[9]   Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling [J].
Dhar, Debanjan ;
Antonucci, Laura ;
Nakagawa, Hayato ;
Kim, Ju Youn ;
Glitzner, Elisabeth ;
Caruso, Stefano ;
Shalapour, Shabnam ;
Yang, Ling ;
Valasek, Mark A. ;
Lee, Sooyeon ;
Minnich, Kerstin ;
Seki, Ekihiro ;
Tuckermann, Jan ;
Sibilia, Maria ;
Zucman-Rossi, Jessica ;
Karin, Michael .
CANCER CELL, 2018, 33 (06) :1061-+
[10]   Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease [J].
Estes, Chris ;
Razavi, Homie ;
Loomba, Rohit ;
Younossi, Zobair ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :123-133